# The Kentucky Viral Hepatitis Treatment Study

> **NCT03949764** · PHASE4 · COMPLETED · sponsor: **Jennifer Havens** · enrollment: 374 (actual)

## Conditions studied

- Hepatitis C
- Opioid-Related Disorders
- Injection Drug Use

## Interventions

- **DRUG:** Sofosbuvir/velpatasvir (Epclusa®)

## Key facts

- **NCT ID:** NCT03949764
- **Lead sponsor:** Jennifer Havens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-23
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949764, "The Kentucky Viral Hepatitis Treatment Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03949764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*